Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and safety of LY3298176, a novel dual GIP and GL... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
0
Authors
Juan Frías
•
Michael Nauck
8 more
•
Axel Haupt
Published
October 4, 2018
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Pathology
Internal Medicine
Endocrinology
Gastroenterology
Medicine
Pathology
Internal Medicine
Endocrinology
Gastroenterology
Show all topics
DOI
10.1016/s0140-6736(18)32260-8
